Form 8-K HEALTHEQUITY, INC. For: Sep 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
HealthEquity, Inc (HQY) PT Raised to $103 at Deutsche Bank
September 4, 2024 12:49 PM EDTDeutsche Bank analyst George Hill raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $103.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Solid Q2 Beat On Broad-based Strength: HQY reported another strong quarter with F2Q total revenue of $299.9 million coming in... More
HealthEquity, Inc (HQY) PT Lowered to $100 at BofA Securities
September 4, 2024 5:24 AM EDTBofA Securities analyst Allen Lutz lowered the price target on HealthEquity, Inc (NASDAQ: HQY) to $100.00 (from $105.00) while maintaining a Buy rating.
The analyst comments "Our Buy thesis for HealthEquity is predicated on faster than market organic growth, supplemented by portfolio M&A, and further enhanced by operating leverage. To date, the biggest driver of... More
HealthEquity, Inc (HQY) PT Raised to $110 at BTIG
September 4, 2024 5:10 AM EDTBTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 while maintaining a Buy rating.
The analyst comments "On Tuesday, 9/3/24 AMC, HQY reported excellent F2Q:25 results. Total revenue of $299.9M +23% y/y exceeded BTIG / consensus estimates of... More
